What is Medway?
Medway operates as a specialized edtech enterprise dedicated to improving the quality of healthcare in Brazil through comprehensive educational initiatives. By focusing on the professional development of medical practitioners, the company addresses critical gaps in clinical training and healthcare delivery. Medway's market position is defined by its commitment to integrating scientific advancements with accessible digital learning, effectively bridging the gap between traditional medical education and the evolving needs of the modern healthcare landscape. The firm serves as a vital conduit for knowledge dissemination, ensuring that healthcare providers are equipped with the latest evidence-based practices to improve patient outcomes.
How much funding has Medway raised?
Medway has raised a total of $14.8M across 1 funding round:
Series A
$14.8M
Series A (2022): $14.8M with participation from GFC, Neurone Ventures, SoftBank Group Corp, EquitasVC, GrãoVC Ventures, ScaleUp Endeavor, AGGIR Ventures, and Allievo Capital
Key Investors in Medway
Neurone Ventures
Founded in 1997, Neurone Ventures II is an Israeli pioneer in seed financing, investing globally with a focus on technology-driven companies.
SoftBank Group Corp
SoftBank Group Corp. is a global technology holding company driving innovation across telecommunications, internet services, artificial intelligence, and IoT through its diverse portfolio and strategic investment platforms.
AGGIR Ventures
Aggir Ventures Health is an investment management firm specializing in the health sector, focused on investing in high-potential businesses to improve healthcare in Brazil through digital and scientific advancements.
What's next for Medway?
With the successful closure of this major strategic investment, Medway is poised to execute an aggressive expansion strategy aimed at solidifying its leadership in the Brazilian health-education market. The company is expected to prioritize the development of new digital tools and the scaling of its existing platform to reach a broader demographic of medical professionals. Furthermore, the involvement of high-profile investors suggests a focus on long-term operational excellence and the potential for future market consolidation. As Medway continues to refine its pedagogical approach, the focus will likely shift toward enhancing user engagement and demonstrating measurable improvements in clinical competency, thereby reinforcing its value proposition to both students and institutional partners in the healthcare ecosystem.
See full Medway company page
